KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 71 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $363,571 | +8.3% | 37,754 | +1.2% | 0.05% | 0.0% |
| Q2 2023 | $335,754 | +14.4% | 37,306 | -0.1% | 0.05% | +15.0% |
| Q1 2023 | $293,500 | -7.7% | 37,341 | -20.6% | 0.04% | -21.6% |
| Q4 2022 | $318,017 | +128.8% | 47,044 | +233.3% | 0.05% | +325.0% |
| Q2 2022 | $139,000 | -29.8% | 14,113 | -13.5% | 0.01% | -7.7% |
| Q2 2020 | $198,000 | +33.8% | 16,325 | -15.4% | 0.01% | +8.3% |
| Q1 2020 | $148,000 | -65.3% | 19,300 | -19.4% | 0.01% | -53.8% |
| Q4 2019 | $427,000 | – | 23,952 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |